Efficacy of postoperative prophylactic antibiotics in reducing permanent pacemaker infections

Wen-Huang Lee1, Ting-Chun Huang2, Li-Jen Lin3

  • 1Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Clinical Cardiology
|April 27, 2017
PubMed
Abstract

Insights

Postoperative prophylactic antibiotics did not reduce infection rates in pacemaker patients. Preoperative antibiotics alone are as effective as adding postoperative doses, suggesting limited clinical benefit for extended antibiotic use.

Area of Science:

  • Cardiology
  • Infectious Disease
  • Medical Device Technology

Background:

  • Limited evidence supports routine postoperative prophylactic antibiotics for permanent pacemaker implantation.
  • Current practice often includes postoperative antibiotics despite uncertain clinical utility.

Purpose of the Study:

  • To investigate the efficacy of postoperative prophylactic antibiotics in preventing device-related infections after pacemaker procedures.
  • To determine if adding postoperative antibiotics to preoperative prophylaxis offers additional benefit.

Main Methods:

  • A prospective study of 367 patients undergoing pacemaker implantation or replacement.
  • Patients received preoperative prophylactic antibiotics; postoperative antibiotics were administered at physician discretion.
  • Primary endpoint was device-related infection, with an average follow-up of 16 months.

Main Results:

  • No significant difference in device-related infection rates between patients receiving preoperative antibiotics only (0.9%) and those receiving both preoperative and postoperative antibiotics (1.5%).
  • Younger age was identified as an independent risk factor for infective complications in multivariate analysis.
  • The observed infection rates were statistically similar between the two antibiotic regimens (P = 0.624).

Conclusions:

  • Postoperative prophylactic antibiotics do not appear to offer additional benefit in reducing infection rates for pacemaker patients.
  • Preoperative antibiotic prophylaxis alone may be sufficient, warranting further investigation.
  • Findings suggest a potential de-escalation of antibiotic use in this patient population.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
293
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
386
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
405
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
487
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
268
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
234